Cassone, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.908
AS - Asia 5.864
EU - Europa 4.460
SA - Sud America 906
AF - Africa 163
OC - Oceania 85
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.391
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.616
SG - Singapore 1.791
CN - Cina 1.468
IT - Italia 1.294
GB - Regno Unito 951
HK - Hong Kong 648
BR - Brasile 643
VN - Vietnam 603
SE - Svezia 467
DE - Germania 318
FI - Finlandia 309
FR - Francia 235
BD - Bangladesh 231
RU - Federazione Russa 218
KR - Corea 195
JP - Giappone 159
TR - Turchia 154
IN - India 150
CA - Canada 149
ID - Indonesia 144
UA - Ucraina 117
IE - Irlanda 109
AR - Argentina 97
MX - Messico 92
NL - Olanda 77
AU - Australia 75
BG - Bulgaria 72
PK - Pakistan 56
IQ - Iraq 51
TN - Tunisia 51
PL - Polonia 47
LT - Lituania 45
ZA - Sudafrica 40
CL - Cile 34
EC - Ecuador 34
MY - Malesia 32
CO - Colombia 30
ES - Italia 30
AT - Austria 25
PE - Perù 24
PT - Portogallo 22
PH - Filippine 21
SA - Arabia Saudita 20
AE - Emirati Arabi Uniti 19
VE - Venezuela 19
HU - Ungheria 18
JO - Giordania 17
EG - Egitto 15
NP - Nepal 15
BZ - Belize 14
KE - Kenya 14
MA - Marocco 14
BE - Belgio 13
DK - Danimarca 12
DZ - Algeria 12
IR - Iran 12
RS - Serbia 11
CH - Svizzera 10
NZ - Nuova Zelanda 10
RO - Romania 10
PY - Paraguay 9
TW - Taiwan 9
TH - Thailandia 8
UZ - Uzbekistan 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
LB - Libano 7
LV - Lettonia 7
CZ - Repubblica Ceca 6
HN - Honduras 6
OM - Oman 6
UY - Uruguay 6
AZ - Azerbaigian 5
BY - Bielorussia 5
CY - Cipro 5
GR - Grecia 5
HR - Croazia 5
IL - Israele 5
JM - Giamaica 5
EU - Europa 4
GT - Guatemala 4
LU - Lussemburgo 4
MD - Moldavia 4
MU - Mauritius 4
TT - Trinidad e Tobago 4
EE - Estonia 3
GY - Guiana 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
KZ - Kazakistan 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
ET - Etiopia 2
Totale 21.365
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.276
Singapore 1.146
Ashburn 1.010
Fairfield 853
Hong Kong 625
Chandler 507
San Jose 486
Southend 451
Hefei 449
Woodbridge 341
Houston 293
Seattle 278
Council Bluffs 272
Nyköping 264
Wilmington 263
Helsinki 261
London 261
Cambridge 240
Beijing 228
Ann Arbor 215
The Dalles 214
Los Angeles 197
Ho Chi Minh City 181
New York 178
Seoul 165
Jacksonville 143
Hanoi 134
Milan 125
Dallas 123
Modena 123
Dearborn 110
Chicago 109
Jakarta 105
San Diego 97
Shanghai 88
Moscow 79
Dublin 76
Buffalo 71
Rome 70
Sofia 70
Lauterbourg 68
Princeton 68
Redwood City 64
São Paulo 62
Tokyo 60
Orem 58
Munich 56
Bologna 49
Perth 47
Salt Lake City 46
Frankfurt am Main 42
Izmir 41
Bremen 39
Montreal 38
Boardman 36
Eugene 36
Da Nang 35
Columbus 34
Mexico City 34
Manchester 33
Toronto 33
Elk Grove Village 29
Nuremberg 29
San Francisco 27
Chennai 26
Kent 26
Warsaw 26
Brooklyn 25
Falls Church 25
Haiphong 25
Mumbai 24
Ankara 22
Atlanta 22
Bari 22
Boston 21
Istanbul 21
Redondo Beach 21
Rio de Janeiro 21
Santiago 21
Amsterdam 20
Phoenix 20
Baghdad 19
Paris 19
Turku 19
Dong Ket 18
Johannesburg 18
Naples 18
Denver 16
Guangzhou 16
Ottawa 16
Quito 16
Stockholm 16
Bogotá 15
Brasília 15
Buenos Aires 15
Catania 15
Las Vegas 15
Amman 14
Belize City 14
Lappeenranta 14
Totale 13.937
Salva come PNG Salva come JPEG
Nome #
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.360
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 414
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 404
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 348
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 347
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 346
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 340
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 323
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 323
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 318
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 315
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 308
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 304
Caratteristiche cliniche e nuovi orizzonti diagnostico-terapeutici delle vasculiti dei grandi vasi e della interstiziopatia polmonare secondaria ad artrite reumatoide. 303
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 302
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 292
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 289
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 288
High-dose glucocorticoids pulse-Therapy for beta-coronaviridae pneumonia: A systematic literature review and case-series of coronavirus disease-2019 288
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 283
The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients 274
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study 258
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 257
[18F]fluorodeoxyglucose positron emission tomography imaging in a case of relapsing polychondritis 256
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 255
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 248
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 246
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 243
Nailfold Capillaroscopy Characteristics of Antisynthetase Syndrome and Possible Clinical Associations: Results of a Multicenter International Study 240
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 237
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry 237
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 234
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 228
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 228
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 227
Nailfold videocapillaroscopy in antisynthetase syndrome 224
Severe alopecia complicating systemic sclerosis 222
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 220
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 219
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 213
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 208
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 208
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 205
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 202
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 202
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 198
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 198
Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients 197
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 194
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximab 192
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 185
Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial 184
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 182
The rediscovery of hydroxychloroquine in allergic diseases in the covid-19 era 181
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 180
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 179
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 175
NAILFOLD CAPILLAROSCOPIC ALTERATIONS IN DERMATOMYOSITIS AND POLYMYOSITIS 175
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 174
Fibrosing interstitial lung disease in primary Sjogren syndrome 170
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study 169
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 168
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 166
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. 163
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 160
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 159
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 156
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 154
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 154
Effects in soluble immune checkpoints induced by Tocilizumab monotherapy after ultra-short-term glucocorticoids in large vessel – giant cell arteritis patients 153
CLINICAL OUTCOMES OF TREATMENT WITH GOLIMUMAB IN SEROPOSITIVE AND SERONEGATIVE RHEUMATOID ARTHRITIS PATIENTS IN REAL-LIFE SETTINGS. DATA FROM ITALIAN REGISTER GISEA 152
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 151
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 150
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis 145
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 144
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 143
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 141
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 141
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 139
Rheumatoid arthritis related interstitial lung disease 138
Reactive Granulomatous Dermatitis during Anti-TNF Therapy: A Case Report and Review of the Literature 133
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 132
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 132
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 130
Granuloma annulare as a possible new adverse effect of topiramate 128
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 128
FRI0212 THE ROLE OF AGE ON THE CLINICAL PRESENTATION AND RELAPSE RATES IN A LARGE COHORT OF 720 PATIENTS WITH GIANT CELL ARTERITIS 125
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 121
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 119
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 117
From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium” 111
NAILFOLD CAPILLAROSCOPY IN ANTISYNTHETASE SYNDROME (NASCAR): RESULTS OF A MULTICENTER, INTERNATIONAL STUDY OF THE AMERICAN AND EUROPEAN NETWORK OF ANTISYNTHETASE SYNDROME (AENEAS) 107
EARLY DISCONTINUATION OF FIRST LINE BIOLOGICAL TREATMENT WITH ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE ITALIAN GISEA REGISTRY 99
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium" 98
Radiomics to predict the mortality of patients with rheumatoid arthritis-associated interstitial lung disease: A proof-of-concept study 98
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 92
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 92
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysis 91
HARNESSING THE POWER OF RADIOMICS TO PREDICT SURVIVAL IN PATIENTS WITH RA-ILD 90
Reply to the comment on: Hypereosinophilic bronchiolitis in ANCA-associated vasculitis: where does it stand? by Bilgin et al 87
Totale 21.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021139 0 0 0 0 0 0 0 0 0 0 0 139
2021/20221.747 144 106 111 99 91 137 81 91 209 173 321 184
2022/20231.874 211 178 145 138 211 215 87 207 230 47 115 90
2023/20241.590 68 89 75 232 219 125 129 254 47 54 123 175
2024/20254.626 143 68 105 317 951 730 390 204 483 168 446 621
2025/20267.968 521 363 631 914 964 596 1.028 389 879 675 579 429
Totale 21.629